Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Status:
Completed
Trial end date:
2019-12-10
Target enrollment:
Participant gender:
Summary
the study aim to protect patients received anthracyclines containing chemotherapy from
cardiotoxcity induced by anthracyclines derivatives. by using L-carnitine and Silymarin for
protection the heart from anthracyclines toxicities, and in addition its a comparitive study
between L-carnitine and Silymarin.